Pfizer share price: what to expect from Q1 result

When is Pfizer earnings date?

The Pfizer earnings release date is scheduled for the 4 May. The results will cover the groups quarter one (Q1) financial year 2021 (FY21) earnings (January to March 2021).

Pfizer results preview: what does the Street expect?

Pfizer, the research based global biopharmaceutical company, is expected to see low double digit revenue growth for Q1 2021 when compared to the prior year’s comparative period (Q1 2020), although earnings per share for the period are expected to be relatively flat against the comparative due to an increased cost base.

The average estimates for the upcoming results are as follows:

• Revenue for the quarter expected at $13.6 billion
• Earnings per share (EPS) for the quarter expected at $0.78

How to trade Pfizer Q1 results

The two graphics below provide traders with both a retail short-term view on the stock, as well as an institutional longer-term view on the Pfizer share price, as to how market participants are positioned ahead of the Q1 earnings release.

A Refinitiv poll of 22 analysts maintain a long-term average rating of ‘hold’ for Pfizer (as of 3 May), with two of these analysts recommending a strong buy, five recommending a buy, 15 hold, zero sell and zero strong sell recommendations on the stock.

From a retail trader perspective (as of 3 May), 99% of IG clients with open positions on the Pfizer expect the share price to rise over the near term, while 1% of IG clients with open positions expect the Pfizer price to fall.

Pfizer share price: technical analysis

The Pfizer share price is currently testing resistance of the $33.40 to $39.30 range within which it currently trades.

For a bullish trading scenario, traders will want to see a confirmed (with a daily close) break of the $39.30 level, before targeting a move to the near term high at $42.90. In this scenario, a close below the dotted trend line may be used as a stop loss consideration.

For a bearish trading scenario, a close below the dotted trend line support could indicate that the price is now looking to return to range support at $33.40. In this scenario, $33.40 becomes the downside target, while a close above range resistance at $39.30 could be used as a stop loss consideration for the trade.

In summary

• Pfizer Q1 FY21 results are scheduled for release on the 4 May
• Group revenue for the quarter is expected to be realized at $13.6 billion
• EPS for the quarter is expected to be realized at $0.78
• The majority of IG clients with open positions on Pfizer expect the price to rise in the near term
• A technical analysis view on the Pfizer share price shows a short to medium-term rangebound price environment